University of Colorado, Denver
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).
University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.
University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.
Top-decile sponsor footprint
University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,283 total, page 17 of 26
Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
NCT03482154
CT-Angiography Prior to DIEP Flap Breast Reconstruction
NCT02883387
Comparison of Mepitel Ag vs Antibiotic Ointment Used With Soft Cast Technique for Treatment of Pediatric Burns
NCT02681757
Reducing Sedentary Time in Patients With Heart Failure
NCT02911493
Pilot Study of High Risk Lung Cancer Screening
NCT03683940
Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer.
NCT02332863
Early Intensive Physical Therapy in Subarachnoid Hemorrhage
NCT02675985
Platelet and Tissue cAMP: Novel Biomarkers of Milrinone Efficacy in Children
NCT02728128
Intervention to Reduce Fear of Hypoglycemia and Optimize Type 1 Diabetes Outcomes
NCT03039933
Parental Views Related to Colorado State Legislation About Vaccinations, Schools, and Child Care Centers
NCT02957344
Effect of Two Exercise Programs on Bone Strength and Architecture
NCT02636530
Cardiovascular Outcomes of Low Testosterone
NCT02758431
Cannabis Observational Study on Mood, Inflammation, and Cognition
NCT03522103
Effect of IFN-γ on Innate Immune Cells
NCT02609932
White Adipose Tissue Clocks and High Calorie Feeding
NCT02809482
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
NCT02754570
Periodontal Inflammation and Immunity in Preclinical Rheumatoid Arthritis
NCT02794012
Focused Incentive Spirometry Monitoring to Reduce Postoperative Oxygen Therapy and Respiratory Complications After Bariatric Surgery
NCT03010852
Use of Ultrasonic Bone Scalpel in Adolescent Idiopathic Scoliosis
NCT02781324
Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer
NCT02719691
Preoperative Exercise in Pancreatic Cancer
NCT02648880
Cardiometabolic Profiles of Boys With Klinefelter Syndrome
NCT02723305
Analysis of B Cells From Autoimmune Individuals
NCT02747277
Appetite Regulation in Older-Aged Obese Individuals
NCT02721303
Transdiagnostic Group Intervention for Children With Behavior Problems
NCT02794051
Thoracic Spine Thrust Manipulation for Cervicogenic Headaches: A Randomized Clinical Trial
NCT02708953
Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients
NCT02528942
Nicotinic Agonist Effects on BMI and Neuronal Response
NCT02458313
Diet / Gut Microbiome Interaction and Influence on Inflammatory Disease in HIV Patients
NCT02610374
Trans Health: Evaluation of Markers of Cardio-metabolic Health and Well-being in Transgender Youth
NCT02550431
The Cellular Pharmacology of F-TAF in Dried Blood Spots
NCT02962739
Myeloid to Adipocyte Transdifferentiation in Human Cells
NCT02654925
The Relationship Between Advanced Glycation Endproducts and Diabetes
NCT02662010
Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG)
NCT02523196
Bone and Vascular Health in Postmenopausal Women With Type 1 Diabetes
NCT02693964
Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers
NCT02404805
A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults
NCT02633371
Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study
NCT02612376
Medical Marijuana in the Pediatric Central Nervous System Tumor Population
NCT03052738
Effects of Augmented Renal Clearance on Pharmacokinetic and Pharmacodynamic Properties of Levetiracetam in Subarachnoid Hemorrhage
NCT02866877
Impact of ART Adherence on HIV Persistence and Inflammation
NCT02797093
Normal Values of Oxidative Stress, Taurine, and Related Markers
NCT02649777
Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
NCT02403778
Targeting Physical Activity to Improve Cardiovascular Health in Type 2 Diabetes
NCT02473926
Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD
NCT02494141
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
NCT02278185
Cannabidiol (CBD) and Pediatric Epilepsy
NCT02447198
Effects of EED on Zn Absorption and Retention in Children From a MNP
NCT02758444
Effects of Sofosbuvir/Ledipasvir Treatment on the Pharmacokinetics and Renal Safety of Tenofovir
NCT02588287
Antiviral Pharmacology and Adherence in Drug Users
NCT02573376
What is open in the University of Colorado, Denver pipeline
265 recruiting of 1,283 indexed (21% open); 830 completed (65%).
Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).
Top condition: Obesity (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Denver: open-pipeline peers nationwide
Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,283 trials (± recruiting share)
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Michigan · 1,327 trials · 13% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- Eli Lilly and Company · 1,341 trials · 9% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Cedars-Sinai Medical Center · 21% recruiting · 339 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this University of Colorado, Denver page
1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.
- 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.